Last reviewed · How we verify

NCT05840744

Evaluation of Risk Factors and Outcome of Thrombosis in Children

Status unknown Last updated 3 May 2023
What this trial tests

trial testing complete blood count in Thrombosis in Children in 30 participants. Status unknown.

Timeline
1 May 2023
Primary endpoint
13 April 2024
13 April 2024

Quick facts

Lead sponsorSohag University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date1 May 2023
Primary completion13 April 2024
Estimated completion13 April 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Adults 1 Day to 18, any sex, with Thrombosis in Children. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pediatric thrombosis is multifactorial, and usually risk factors either congenital or acquired are present. Patient may has one risk factor or more such as sepsis, cancers, congenital heart disease, post surgery , central venous catheter insertion, nephrotic syndrome, systemic lupus erythromatosis and inflammatory bowel disease. If there's no obvious risk factor for thrombosis, hereditary thrombophilia is suspected which results when an inherited factor, such as antithrombin , protein C or protein S deficiency.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of complete blood count

Trials testing the same drug.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05840744.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing